Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation.

The existence of loss and gain of chromosomes, known as aneuploidy, has been previously described within the central nervous system. During development, at least one-third of neural progenitor cells (NPCs) are aneuploid. Notably, aneuploid NPCs may survive and functionally integrate into the mature...

Full description

Bibliographic Details
Main Authors: Rafaela C Sartore, Priscila B Campos, Cleber A Trujillo, Bia L Ramalho, Priscilla D Negraes, Bruna S Paulsen, Tamara Meletti, Elaine S Costa, Leonardo Chicaybam, Martin H Bonamino, Henning Ulrich, Stevens K Rehen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3108948?pdf=render
_version_ 1828533304859557888
author Rafaela C Sartore
Priscila B Campos
Cleber A Trujillo
Bia L Ramalho
Priscilla D Negraes
Bruna S Paulsen
Tamara Meletti
Elaine S Costa
Leonardo Chicaybam
Martin H Bonamino
Henning Ulrich
Stevens K Rehen
author_facet Rafaela C Sartore
Priscila B Campos
Cleber A Trujillo
Bia L Ramalho
Priscilla D Negraes
Bruna S Paulsen
Tamara Meletti
Elaine S Costa
Leonardo Chicaybam
Martin H Bonamino
Henning Ulrich
Stevens K Rehen
author_sort Rafaela C Sartore
collection DOAJ
description The existence of loss and gain of chromosomes, known as aneuploidy, has been previously described within the central nervous system. During development, at least one-third of neural progenitor cells (NPCs) are aneuploid. Notably, aneuploid NPCs may survive and functionally integrate into the mature neural circuitry. Given the unanswered significance of this phenomenon, we tested the hypothesis that neural differentiation induced by all-trans retinoic acid (RA) in pluripotent stem cells is accompanied by increased levels of aneuploidy, as previously described for cortical NPCs in vivo. In this work we used embryonal carcinoma (EC) cells, embryonic stem (ES) cells and induced pluripotent stem (iPS) cells undergoing differentiation into NPCs. Ploidy analysis revealed a 2-fold increase in the rate of aneuploidy, with the prevalence of chromosome loss in RA primed stem cells when compared to naïve cells. In an attempt to understand the basis of neurogenic aneuploidy, micronuclei formation and survivin expression was assessed in pluripotent stem cells exposed to RA. RA increased micronuclei occurrence by almost 2-fold while decreased survivin expression by 50%, indicating possible mechanisms by which stem cells lose their chromosomes during neural differentiation. DNA fragmentation analysis demonstrated no increase in apoptosis on embryoid bodies treated with RA, indicating that cell death is not the mandatory fate of aneuploid NPCs derived from pluripotent cells. In order to exclude that the increase in aneuploidy was a spurious consequence of RA treatment, not related to neurogenesis, mouse embryonic fibroblasts were treated with RA under the same conditions and no alterations in chromosome gain or loss were observed. These findings indicate a correlation amongst neural differentiation, aneuploidy, micronuclei formation and survivin downregulation in pluripotent stem cells exposed to RA, providing evidence that somatically generated chromosomal variation accompanies neurogenesis in vitro.
first_indexed 2024-12-11T23:07:32Z
format Article
id doaj.art-00fa36eed241439fad283bfadedbf8f1
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T23:07:32Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-00fa36eed241439fad283bfadedbf8f12022-12-22T00:46:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0166e2066710.1371/journal.pone.0020667Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation.Rafaela C SartorePriscila B CamposCleber A TrujilloBia L RamalhoPriscilla D NegraesBruna S PaulsenTamara MelettiElaine S CostaLeonardo ChicaybamMartin H BonaminoHenning UlrichStevens K RehenThe existence of loss and gain of chromosomes, known as aneuploidy, has been previously described within the central nervous system. During development, at least one-third of neural progenitor cells (NPCs) are aneuploid. Notably, aneuploid NPCs may survive and functionally integrate into the mature neural circuitry. Given the unanswered significance of this phenomenon, we tested the hypothesis that neural differentiation induced by all-trans retinoic acid (RA) in pluripotent stem cells is accompanied by increased levels of aneuploidy, as previously described for cortical NPCs in vivo. In this work we used embryonal carcinoma (EC) cells, embryonic stem (ES) cells and induced pluripotent stem (iPS) cells undergoing differentiation into NPCs. Ploidy analysis revealed a 2-fold increase in the rate of aneuploidy, with the prevalence of chromosome loss in RA primed stem cells when compared to naïve cells. In an attempt to understand the basis of neurogenic aneuploidy, micronuclei formation and survivin expression was assessed in pluripotent stem cells exposed to RA. RA increased micronuclei occurrence by almost 2-fold while decreased survivin expression by 50%, indicating possible mechanisms by which stem cells lose their chromosomes during neural differentiation. DNA fragmentation analysis demonstrated no increase in apoptosis on embryoid bodies treated with RA, indicating that cell death is not the mandatory fate of aneuploid NPCs derived from pluripotent cells. In order to exclude that the increase in aneuploidy was a spurious consequence of RA treatment, not related to neurogenesis, mouse embryonic fibroblasts were treated with RA under the same conditions and no alterations in chromosome gain or loss were observed. These findings indicate a correlation amongst neural differentiation, aneuploidy, micronuclei formation and survivin downregulation in pluripotent stem cells exposed to RA, providing evidence that somatically generated chromosomal variation accompanies neurogenesis in vitro.http://europepmc.org/articles/PMC3108948?pdf=render
spellingShingle Rafaela C Sartore
Priscila B Campos
Cleber A Trujillo
Bia L Ramalho
Priscilla D Negraes
Bruna S Paulsen
Tamara Meletti
Elaine S Costa
Leonardo Chicaybam
Martin H Bonamino
Henning Ulrich
Stevens K Rehen
Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation.
PLoS ONE
title Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation.
title_full Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation.
title_fullStr Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation.
title_full_unstemmed Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation.
title_short Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation.
title_sort retinoic acid treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation
url http://europepmc.org/articles/PMC3108948?pdf=render
work_keys_str_mv AT rafaelacsartore retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation
AT priscilabcampos retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation
AT cleberatrujillo retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation
AT bialramalho retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation
AT priscilladnegraes retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation
AT brunaspaulsen retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation
AT tamarameletti retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation
AT elainescosta retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation
AT leonardochicaybam retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation
AT martinhbonamino retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation
AT henningulrich retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation
AT stevenskrehen retinoicacidtreatedpluripotentstemcellsundergoingneurogenesispresentincreasedaneuploidyandmicronucleiformation